<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03848052</url>
  </required_header>
  <id_info>
    <org_study_id>ESMEAMLC</org_study_id>
    <nct_id>NCT03848052</nct_id>
  </id_info>
  <brief_title>Evolution of the Therapeutic Care in Advanced or Metastatic Lung Cancer From 2013 (ESME-AMLC)</brief_title>
  <official_title>Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Advanced or Metastatic Lung Cancer in France From 2013</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UNICANCER</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>UNICANCER</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ESME AMLC Data Platform is a multi-center real life database using a retrospective data&#xD;
      collection process in France over 36 sites. This database compiles data from Patient's&#xD;
      Electronic medical records (EMR), inpatient Hospitalisation records and Pharmacy records.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This database compiles data from Patient's Electronic medical records (EMR), inpatient&#xD;
      Hospitalisation records and Pharmacy records.&#xD;
&#xD;
      Patient Database: Patient-related data integrates data from non-structured sources&#xD;
      (electronic medical records), such as patient medical records and reports of multidiscipline&#xD;
      team meetings. It can provide information on patient demographics, primitive tumour,&#xD;
      relapses, pathology reports, metastatic disease, therapeutic care/settings and withdrawal&#xD;
      reasons when applicable and clinical events.&#xD;
&#xD;
      Treatment Database: Pharmacy records-related data is a structured database including all data&#xD;
      pertaining to medications prescribed and dispensed by pharmacies within each center,&#xD;
      specifically chemotherapy and co-prescriptions. It does not contain information on products&#xD;
      that are prescribed or delivered outside of the center. From each center's pharmacy database,&#xD;
      information on systemic treatment patterns (dates, pharmaceutical forms, treatment protocols,&#xD;
      etc.) can be obtained.&#xD;
&#xD;
      Hospitalization Database: Hospitalisation-related data is a structured and systematic&#xD;
      database that contains all medical data reported related to any hospitalisation in the&#xD;
      contributing center, and is used to bill the French National Health Insurance Fund (Assurance&#xD;
      Maladie). It provides information on patient entry and discharge dates as well as diagnostic&#xD;
      and therapeutic procedures performed, including radiotherapy and surgery.&#xD;
&#xD;
      Data imported into the final database are controlled, recoded, and harmonized before import&#xD;
      according to a data management plan. All coding procedures are predefined by the data&#xD;
      manager. There is no transmission of individual data; all data are centralized within each&#xD;
      center using a shared anonymous format. All data are exclusively obtained retrospectively; no&#xD;
      attempts are made to recover non available data from the patient's medical record by&#xD;
      contacting healthcare providers or patients.&#xD;
&#xD;
      ESME AMLC Data Platform aims to be a clinical and therapeutic database centralising existing&#xD;
      and available data from different sources used in the contributing centers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2, 2017</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient characteristics</measure>
    <time_frame>Baseline</time_frame>
    <description>Aage in years, Tobacco consumption, other exposures, Legal recognition as occupational disease, Medical history, History of other cancer, weight in kg and performance status (ECOG)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>tumor characteristics</measure>
    <time_frame>Baseline</time_frame>
    <description>Staging, Tumor size, sampling Method, histological type</description>
  </primary_outcome>
  <primary_outcome>
    <measure>treatment patterns</measure>
    <time_frame>From Baseline until 2024 (yearly basis)</time_frame>
    <description>Drug, therapeutic class, treatment duration at each n treatment line</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Median overall survival</measure>
    <time_frame>From date of diagnosis or first treatment until the date of death from any cause. Follow up until 2024</time_frame>
    <description>Assessment of overall survival through treatment lines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median surrogate endpoints for overall survival</measure>
    <time_frame>From start date of the nth treatment line until the date of first applicable event. Follow up until 2024</time_frame>
    <description>Surrogate endpoints (Progression-free Survival, Time to Progression, Time to Next Treatment) at each n treatment line.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">26000</enrollment>
  <condition>Lung Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients treated for an ovarian cancer in the 36 French contributing&#xD;
        centers.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria :&#xD;
&#xD;
          -  Patient treated in first -line treatment for a lung cancer over the selection period&#xD;
             in one of the participating center&#xD;
&#xD;
          -  Patient receiving a therapeutic care defined as chemotherapy, targeted therapy,&#xD;
             immunotherapy, radiation therapy, diagnostic procedure, other specific therapeutic&#xD;
             procedure)&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
        - None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Laure Martin, Pharmacist</last_name>
    <role>Study Director</role>
    <affiliation>UNICANCER</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathieu Robain, MD, PhD</last_name>
    <phone>0033144235553</phone>
    <email>m-robain@unicancer.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gaëtane Simon, Msc</last_name>
    <phone>0033173797300</phone>
    <email>g-simon@unicancer.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut de Cancérologie de l'Ouest - Paul Papin</name>
      <address>
        <city>Angers,</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geneviève PERROCHEAU</last_name>
      <phone>+33 2 40 67 99 77</phone>
      <email>genevieve.perrocheau@ico.unicancer.fr</email>
    </contact>
    <contact_backup>
      <last_name>Loïc CAMPION</last_name>
      <email>loic.campion@ico.unicancer.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Institut Bergonié</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne JAFFRE</last_name>
      <phone>+33 5 56 33 78 48</phone>
      <email>a.jaffre@bordeaux.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre François Baclesse</name>
      <address>
        <city>Caen</city>
        <zip>14076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Valérie GUIZARD</last_name>
      <phone>+33 2 31 45 52 45</phone>
      <email>av.guizard@baclesse.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Jean Perrin</name>
      <address>
        <city>Clermont-ferrand</city>
        <zip>63011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Ange MOURET-REYNIER</last_name>
      <phone>+33 4 73 27 81 37</phone>
      <email>marie-ange.mouret-reynier@clermont.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Intercommunal de Créteil</name>
      <address>
        <city>Creteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christos CHOUAID</last_name>
      <phone>+33 1 57 02 20 70</phone>
      <email>christos.chouaid@chicreteil.fr</email>
    </contact>
    <contact_backup>
      <last_name>David MAHN</last_name>
      <phone>+331 57 02 26 14</phone>
      <email>David.Manh@chicreteil.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centre Georges-François Leclerc</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandrine DABAYUKO</last_name>
      <phone>0033 3 45 34 80 67</phone>
      <email>sdabakuyo@cgfl.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <zip>59020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Paule LEBITASY</last_name>
      <phone>0033 3 20 29 55 60</phone>
      <email>m-lebitasy@o-lambret.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Léon Bérard</name>
      <address>
        <city>Lyon</city>
        <zip>69373</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas BACHELOT</last_name>
      <phone>+33 4 78 78 26 54</phone>
      <email>thomas.bachelot@lyon.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Paoli-Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13273</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lilian LABORDE</last_name>
      <phone>+33 4 91 22 35 10</phone>
      <email>LABORDEL@ipc.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut régional du Cancer Montpellier / Val d'Aurelle</name>
      <address>
        <city>Montpellier</city>
        <zip>34298</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphanie DELAINE</last_name>
      <phone>+33 4 67 61 47 39</phone>
      <email>stephaine.delaine@icm.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Région Mulhouse et Sud Alsace - Hôpital Emile Muller</name>
      <address>
        <city>Mulhouse</city>
        <zip>68070</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier DEBIEUVRE</last_name>
      <phone>+33 3 89 64 73 96</phone>
      <email>debieuvred@ch-mulhouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Arnaud MULHOUSE</last_name>
      <phone>+33 3 89 64 67 53</phone>
      <email>etiennea@ghrmsa.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Institut de cancérologie de l'Ouest - René Gauducheau</name>
      <address>
        <city>Nantes</city>
        <zip>44805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geneviève PERROCHEAU</last_name>
      <phone>+33 2 40 67 99 77</phone>
      <email>genevieve.perrocheau@ico.unicancer.fr</email>
    </contact>
    <contact_backup>
      <last_name>Loïc CAMPION</last_name>
      <email>loic.campion@ico.unicancer.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centre Antoine Lacassagne</name>
      <address>
        <city>Nice</city>
        <zip>06189</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel CHAMOREY</last_name>
      <phone>+33 4 92 03 15 29</phone>
      <email>emmanuel.chamorey@nice.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Curie</name>
      <address>
        <city>Paris</city>
        <zip>75005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Etienne BRAIN</last_name>
      <phone>0033144324685</phone>
      <email>etienne.brain@curie.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Jean Godinot</name>
      <address>
        <city>Reims</city>
        <zip>51056</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damien PARENT</last_name>
      <phone>+33 3 26 50 42 76</phone>
      <email>damien.parent@reims.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen</city>
        <zip>76038</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnès LOEB</last_name>
      <phone>+33 2 32 08 22 80</phone>
      <email>agnes.loeb@chb.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Curie - Hôpital René Huguenin</name>
      <address>
        <city>Saint-Cloud</city>
        <zip>92210</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Etienne BRAIN</last_name>
      <phone>+33 1 47 11 15 15</phone>
      <email>etienne.brain@curie.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Paul Strauss</name>
      <address>
        <city>Strasbourg</city>
        <zip>67065</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel VELTEN</last_name>
      <phone>+33 3 88 25 24 53</phone>
      <email>mvelten@strasbourg.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Claudius Regaud</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine BERCHERY</last_name>
      <phone>05 31 15 50 60</phone>
      <email>Berchery.Delphine@iuct-oncopole.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut de Cancérologie de Lorraine</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <zip>54519</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carine LAURENT</last_name>
      <phone>+33 3 83 59 83 32</phone>
      <email>c.laurent@nancy.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie DEJEAN</last_name>
      <phone>+33 1 42 11 46 49</phone>
      <email>valerie.dejean@gustaveroussy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Robain M, Pérol M, Girard N, Debieuvre D, Coudert B, Madroszyk A, et al. Programme épidémio-stratégie médicoéconomique : une base nationale de données de vie réelle pour mieux comprendre la prise en charge du cancer bronchopulmonaire en France. Revue des Maladies Respiratoires. 2018 Jan;35:A106.</citation>
  </reference>
  <results_reference>
    <citation>Girard, N., M. Pérol, G. Simon, C. Audigier Valette, R. Gervais, D. Debieuvre, R. Schott, et al. &quot; 90P - Real-world treatment patterns, clinical practice and outcomes for locally advanced, non resectable, non-small cell lung cancer from the French ESME Lung database &quot;. Abstract Book of the European Lung Cancer Congress (ELCC) 10-13 April 2019, Geneva, Switzerland 30 (1 avril 2019): ii34. https://doi.org/10.1093/annonc/mdz067.006.</citation>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 25, 2018</study_first_submitted>
  <study_first_submitted_qc>February 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2019</study_first_posted>
  <last_update_submitted>March 22, 2021</last_update_submitted>
  <last_update_submitted_qc>March 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lung cancer</keyword>
  <keyword>observational study</keyword>
  <keyword>survival</keyword>
  <keyword>real world data</keyword>
  <keyword>real life setting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

